Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin.

The trailing-twelve-month operating margin at Meridian Bioscience (NASDAQ: VIVO) is 30.48%. Meridian Bioscience's revenue for the same period is $184.04 million.

The trailing-twelve-month operating margin at Trinity Biotech plc (NASDAQ: TRIB) is 19.75%. Trinity Biotech's PEG ratio is 1.38.

The trailing-twelve-month operating margin at Neogen (NASDAQ: NEOG) is 19.61%. Neogen's ROE for the same period is 11.33%.

The trailing-twelve-month operating margin at Abaxis (NASDAQ: ABAX) is 13.21%. Abaxis had $85.54 million in total cash for the latest quarter.